Generic Name and Formulations:
Caprylic triglyceride, potassium caseinate (milk-derived protein), maltodextrin, whey protein (milk-derived), sugar, sunflower oil, dimagnesium phosphate, tricalcium phosphate, dipotassium phosphate, soy lecithin, distilled monoglyceride, silicon dioxide, natural vanilla bean extract, sucralose, acesulfame potassium; pwd; 40g per packet.
Indications for AXONA:
Dietary management of the metabolic processes associated with mild to moderate Alzheimer's disease.
1 packet once daily after meals; add contents of packet in 4–8oz of water or preferred liquids, mix thoroughly. May start with a graduated dosing regimen for 7 days before taking one full packet per day.
Milk or soy allergy.
Risk of ketoacidosis (eg, alcoholics, poorly controlled diabetics). History of GI inflammatory conditions (eg, IBS, diverticular disease, chronic gastritis, severe GERD). Renal dysfunction. Monitor triglyceride levels during therapy.
GI upset, flatulence, dyspepsia, dizziness, headache, increases in BUN, uric acid, or creatinine.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Serious Adverse Events Profile for Cladribine Confirmed With Extended Data
- Unintended Pregnancy Common in Women With Epilepsy
- Aggressive Blood Pressure Lowering in Intracerebral Hemorrhage May Be Harmful
- Risk of Opioid-Benzodiazepine Overlap Up for Dual Prescribing
- Minority Residents Experience Burdens Linked to Race/Ethnicity
- Tips Provided for Budgeting in Medical Residency